Concerns About Mobic Use in Early Pregnancy: What to Expect?

During the early stages of pregnancy (3-4 weeks), one dose of Mobic 15mg was taken?

Hello Doctor, I confirmed my pregnancy on March 22 (the first day of my last menstrual period was January 29).
However, before I realized I was pregnant (around March 19), I experienced abdominal pain at night, mistook it for menstrual cramps, and took Mobic (Meloxicam) at a dosage of 15mg.
Recently, I found information indicating that this medication can increase the risk of fetal heart defects, abdominal wall defects, or even stillbirth during early pregnancy.
When can I determine if my baby is healthy? Are there any tests I can do to detect fetal abnormalities early? I'm really worried, and I appreciate your response.

Weiwei, 20~29 year old female. Ask Date: 2017/04/08

Dr. Huang Jianzhong reply Obstetrics and Gynecology

On March 22, I confirmed my pregnancy (with the first day of my last menstrual period being January 29).
However, prior to discovering my pregnancy (around March 19), I experienced abdominal pain at night, mistaking it for menstrual cramps, and took Mobic (meloxicam) at a dosage of 15 mg.
Recently, I found information indicating that this medication can increase the risk of fetal heart defects, abdominal wall defects, or even stillbirth during early pregnancy.
When can I confirm if my baby is healthy? Are there any tests I can do to detect fetal abnormalities early? I am really worried, and I appreciate your response.
Mobic® Tablets 7.5 mg/15 mg (manufactured by Boehringer Ingelheim) is a non-steroidal anti-inflammatory drug (NSAID) of the enolic acid class, which has anti-inflammatory, analgesic, and antipyretic effects.
In standard models of inflammation, Mobic has shown strong anti-inflammatory properties.
The common mechanism of action for these effects is the inhibition of the synthesis of prostaglandins, which are mediators of inflammation.

Regarding fertility, pregnancy, and lactation, Mobic is contraindicated during pregnancy.
The inhibition of prostaglandin synthesis can have adverse effects on pregnancy and/or fetal development.
Epidemiological studies have found that the use of prostaglandin synthesis inhibitors in early pregnancy increases the risk of miscarriage, heart defects, and abdominal wall defects (gastrochisis).
The absolute risk of heart defects increases from less than 1% to nearly 1.5%.
This risk increases with the dosage and duration of treatment.
Preclinical studies have shown that the administration of prostaglandin synthesis inhibitors increases the failure rates of implantation and embryo death both before and after implantation.
Additionally, preclinical studies have reported that administering prostaglandin synthesis inhibitors during the organogenesis period increases the chances of various malformations, including cardiovascular defects.
In the third trimester of pregnancy, prostaglandin synthesis inhibitors may pose risks to the fetus, including:
- Cardiotoxicity (premature closure of the ductus arteriosus and pulmonary hypertension)
- Renal impairment, which may progress to renal failure associated with oligohydramnios.
For women in late pregnancy and newborns, it may lead to:
- Prolonged bleeding time, with even low doses potentially causing anticoagulant effects.
- Inhibition of uterine contractions, resulting in delayed labor or prolonged delivery.
Although there is currently no direct data linking Mobic to these outcomes, it is known that NSAIDs can be excreted in breast milk, thus their use is contraindicated in breastfeeding women.
During prenatal check-ups, it is essential to inform the physician about these concerns.

Reply Date: 2017/04/08

More Info

Using Mobic (meloxicam) during early pregnancy raises significant concerns due to its classification as a non-steroidal anti-inflammatory drug (NSAID). Research indicates that the use of NSAIDs, particularly in the first trimester, can increase the risk of congenital anomalies, including cardiac defects and gastrochisis (a type of abdominal wall defect). The risk of these complications is heightened with the dosage and duration of use, making it crucial for expectant mothers to be aware of the potential implications of any medication taken during this sensitive period.

Given that you took Mobic shortly before discovering your pregnancy, it is understandable to feel anxious about the health of your baby. The first trimester is a critical time for fetal development, and many structural abnormalities can occur during this period. However, it is important to note that not all exposure to medications leads to adverse outcomes, and the actual risk can vary based on numerous factors, including the timing of exposure, dosage, and individual health conditions.

To assess the health of your baby and to check for potential abnormalities, several screening and diagnostic tests are available:
1. Ultrasound: The first-trimester ultrasound, typically performed between 11 to 14 weeks, can help assess fetal development and detect some structural anomalies. This scan can also measure the nuchal translucency, which can indicate the risk of chromosomal abnormalities.

2. Non-Invasive Prenatal Testing (NIPT): This blood test analyzes fetal DNA circulating in the mother's blood and can provide information about certain genetic conditions, such as Down syndrome. While it does not specifically test for structural defects, it can give you peace of mind regarding chromosomal health.

3. Second Trimester Ultrasound: A more detailed anatomy scan is usually performed between 18 to 20 weeks. This ultrasound can provide a comprehensive evaluation of the baby's organs and structures, allowing for the detection of many congenital anomalies.

4. Amniocentesis or Chorionic Villus Sampling (CVS): If there are significant concerns based on initial screenings or family history, invasive testing such as amniocentesis (performed around 15-20 weeks) or CVS (performed between 10-13 weeks) can be considered. These tests can provide definitive information about chromosomal conditions but do carry a small risk of miscarriage.

5. Consultation with a Maternal-Fetal Medicine Specialist: If you have heightened concerns, it may be beneficial to consult with a specialist in high-risk pregnancies. They can provide tailored advice and additional monitoring throughout your pregnancy.

While it is natural to feel worried, it is essential to approach this situation with a balanced perspective. Many women have taken medications during early pregnancy without adverse effects on their babies. Open communication with your healthcare provider is crucial; they can guide you through the available options for monitoring and testing, ensuring that you receive the best care possible.

In summary, while Mobic use in early pregnancy is associated with certain risks, proactive monitoring and testing can help assess the health of your baby. Regular prenatal care and discussions with your healthcare provider will be key in navigating your concerns and ensuring a healthy pregnancy.

Similar Q&A

Common Pregnancy Concerns: Folic Acid, Phone Use, and Medication Effects

Hello Dr. Huang: I am currently about 5 weeks pregnant and a few days ago I bought a box of Slow-Fo Folic® Tablets for supplementation. I have noticed that my stools have been dark green for the past few days. Is this normal, or does it mean that the iron and folic acid I consume...

Dr. Huang Jianxun reply Obstetrics and Gynecology
The use of iron supplements may cause stools to turn dark green. To enhance the absorption of iron in the gastrointestinal tract, it can be taken in conjunction with vitamin B complex (especially B-12). The potential harm of mobile phone radiation to the human body is still under...

Concerns About Medication Use During Pregnancy: Metronidazole Risks

I am currently 11 weeks and 5 days pregnant. When I was 7 weeks along, I went to the obstetrics and gynecology department for an ultrasound and reported my vaginal inflammation. The doctor prescribed me capsules (appearance KJ179), instructing me to take two capsules twice a day,...

Dr. Cao Guotao reply Obstetrics and Gynecology
Hello, the grading seems to be B, which should be fine. If you have any concerns, it's best not to continue taking it. Wishing you good health.

Concerns About Cold Medicine Use During Early Pregnancy: What to Know

Hello, doctor. I have been taking cold medication during the early weeks of my pregnancy without knowing I was pregnant, and I am currently experiencing signs of a threatened miscarriage (brownish discharge). I have been taking progesterone, but I still notice discharge when I ha...

Dr. Zhang Kunmin reply Obstetrics and Gynecology
Hello, the medications you mentioned are generally considered safe during pregnancy. It is recommended to drink plenty of water and get ample rest. If there is still vaginal bleeding, it is advisable to stay in bed and avoid heavy lifting. If necessary, you may take medications t...

Early Pregnancy: Dietary Concerns and Medication Safety

Hello Dr. Chuang: The first day of my last menstrual period was April 8, and I am currently about four weeks pregnant. During this time, I took an allergy medication that contained: Decadolone 0.5 mg, Tellwell, AlOH 334 mg, Prinate 3 mg, and Buclizine 25 mg. Will this affect my f...

Dr. Zhuang Zhijian reply Obstetrics and Gynecology
1. Taking it only once should not cause significant issues; it is recommended to minimize usage during this period. 2. It should be fine. 3. Currently, there are no research reports indicating that it is necessary to "stay away from the computer."